NASDAQ: BIIB
Biogen Inc Stock Ownership - Who owns Biogen?

Insider buying vs selling

Have Biogen Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sean GodboutCAO2026-10-028$219.88
$1.76kSell
Lloyd MinorDirector2026-08-04593$200.96
$119.17kSell
Lloyd MinorDirector2026-08-03593$203.34
$120.58kSell
Adam KeeneyHead of Corporate Development2026-05-01455$187.06
$85.11kSell
Sean GodboutChief Accounting Officer2026-04-0154$183.78
$9.92kSell
Nicole MurphyHead of Pharm Ops and Tech2026-02-123$195.04
$585.11Buy
Priya SinghalHead of Development2026-02-092,660$199.83
$531.55kSell
Ginger GregoryEVP Human Resources2026-02-06666$201.18
$133.99kSell
Ginger GregoryEVP Human Resources2026-02-061,132$201.18
$227.74kSell
Jane GroganHead of Research2026-02-06407$201.18
$81.88kSell

1 of 4

BIIB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BIIB insiders and whales buy or sell their stock.

BIIB Shareholders

What type of owners hold Biogen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Alexander J. Denner0.45%658,099$164.98MInsider
Phillip A. Sharp0.32%470,278$117.89MInsider
William H. Rastetter0.29%424,606$106.44MInsider
James C. Mullen0.21%303,259$76.02MInsider
Connie Matsui0.07%104,369$26.16MInsider
Cecil B. Pickett0.06%88,732$22.24MInsider
Michel Vounatsos0.05%67,261$16.86MInsider
Susan H. Alexander0.04%61,889$15.51MInsider
George A. Scangos0.04%60,157$15.08MInsider
Hans Peter Hasler0.04%53,261$13.35MInsider

1 of 3

BIIB vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BIIB0.10%2.16%Net SellingNet Selling
GRFS0.02%0.00%
OGN0.08%0.52%Net SellingNet Selling
AMRN0.00%15.85%Net SellingNet Selling
NSRX0.02%45.43%Net Buying

Biogen Stock Ownership FAQ

Who owns Biogen?

Biogen (NASDAQ: BIIB) is owned by 0.10% institutional shareholders, 2.16% Biogen insiders, and 97.74% retail investors. Alexander J. Denner is the largest individual Biogen shareholder, owning 658,099.00 shares representing 0.45% of the company. Alexander J. Denner's Biogen shares are currently valued at $166.01M.

If you're new to stock investing, here's how to buy Biogen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.